Xiaflex and Penile haematoma - a phase IV clinical study of FDA data

Summary:

Penile haematoma is found among people who take Xiaflex, especially for people who are 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Xiaflex and have Penile haematoma. It is created by eHealthMe based on reports of 3,702 people who have side effects when taking Xiaflex from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On Jul, 17, 2022

3,702 people reported to have side effects when taking Xiaflex.
Among them, 183 people (4.94%) have Penile haematoma.

What is Xiaflex?

Xiaflex has active ingredients of collagenase clostridium histolyticum. eHealthMe is studying from 3,704 Xiaflex users for its effectiveness, alternative drugs and more.

What is Penile haematoma?

Penile haematoma (localized collection of blood outside the blood vessels on penis) is found to be associated with 121 drugs and 60 conditions by eHealthMe.

Number of Xiaflex and Penile haematoma reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Xiaflex and have Penile haematoma?

Check whether Penile haematoma is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of Xiaflex:

Xiaflex (3,704 reports)

Penile haematoma treatments and more:

Penile haematoma (220 reports)

COVID vaccines that are related to Penile haematoma:

How severe was Penile haematoma and when was it recovered:

Penile haematoma in Xiaflex

Expand to all the drugs that have ingredients of collagenase clostridium histolyticum:

Penile haematoma and drugs with ingredients of collagenase clostridium histolyticum

Common drugs associated with Penile haematoma:

Xiaflex: 183 reports

All the drugs that are associated with Penile haematoma:

Penile haematoma (121 drugs)

Common conditions associated with Penile haematoma:

Curvature of the penis: 184 reports
Peyronie's disease: 184 reports

All the conditions that are associated with Penile haematoma:

Penile haematoma (60 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on collagenase clostridium histolyticum (the active ingredients of Xiaflex) and Xiaflex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.